Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Skórski

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Folia Histochemica Et Cytobiologica|January 1, 1985
The role of the BCG dose and the mouse strain in the inhibition of development of neoplasms susceptible and nonsusceptible to the action of natural cytotoxic cellsT Skórski
Acta Haematologica Polonica|January 1, 1995
[Progress in molecular biology of leukemias--clinical implications]T Skórski
Acta Haematologica Polonica|January 1, 1994
[Molecular basis of chronic granulocytic leukemia: from test-tube to patient]T Skórski
Folia Histochemica Et Cytobiologica|January 1, 1989
A simple method of bone marrow cryopreservationT Skórski, M Kawalec
Bone Marrow Transplantation|December 1, 1987
Recovery of the ability to induce immune resistance against L1210 lymphatic leukemia in semisyngeneic CD2F1 mice after lethal irradiation and reconstitution with bone marrow purged of leukemia with mafosfamide (ASTA Z 7654)T Skórski, M Kawalec
Experimental Hematology|October 1, 1988
Induction of immune resistance against L1210 lymphatic leukemia in mice after chemoradiotherapy of the leukemia and reconstitution with bone marrow purged from the leukemia with mafosfamideT Skórski, M Kawalec
Investigational New Drugs|January 1, 1987
New application of a stabilized active cyclophosphamide derivative (mafosfamide, ASTA Z 7654)--immunogenic properties of lymphatic leukemia L 1210 cells treated in vitro with the drugT Skórski, M Kawalec
Folia Histochemica Et Cytobiologica|January 1, 1987
Cellular composition of spleen and peritoneal exudate in mice after injection of cyclophosphamide-treated L 1210 leukemia cellsT Skórski, M Kawalec, J Kawiak
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|March 15, 1988
[Use of autologous bone marrow transplants in the treatment of neoplasms]M Nieborowska-Skórska, T Skórski
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1988
Immunogenicity of cyclophosphamide-treated tumor cellsM Kawalec, T Skórski, G Hoser
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Folia Histochemica Et Cytobiologica|January 1, 1985
The role of the BCG dose and the mouse strain in the inhibition of development of neoplasms susceptible and nonsusceptible to the action of natural cytotoxic cellsT Skórski
Acta Haematologica Polonica|January 1, 1995
[Progress in molecular biology of leukemias--clinical implications]T Skórski
Acta Haematologica Polonica|January 1, 1994
[Molecular basis of chronic granulocytic leukemia: from test-tube to patient]T Skórski
Folia Histochemica Et Cytobiologica|January 1, 1989
A simple method of bone marrow cryopreservationT Skórski, M Kawalec
Bone Marrow Transplantation|December 1, 1987
Recovery of the ability to induce immune resistance against L1210 lymphatic leukemia in semisyngeneic CD2F1 mice after lethal irradiation and reconstitution with bone marrow purged of leukemia with mafosfamide (ASTA Z 7654)T Skórski, M Kawalec
Experimental Hematology|October 1, 1988
Induction of immune resistance against L1210 lymphatic leukemia in mice after chemoradiotherapy of the leukemia and reconstitution with bone marrow purged from the leukemia with mafosfamideT Skórski, M Kawalec
Investigational New Drugs|January 1, 1987
New application of a stabilized active cyclophosphamide derivative (mafosfamide, ASTA Z 7654)--immunogenic properties of lymphatic leukemia L 1210 cells treated in vitro with the drugT Skórski, M Kawalec
Folia Histochemica Et Cytobiologica|January 1, 1987
Cellular composition of spleen and peritoneal exudate in mice after injection of cyclophosphamide-treated L 1210 leukemia cellsT Skórski, M Kawalec, J Kawiak
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|March 15, 1988
[Use of autologous bone marrow transplants in the treatment of neoplasms]M Nieborowska-Skórska, T Skórski
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1988
Immunogenicity of cyclophosphamide-treated tumor cellsM Kawalec, T Skórski, G Hoser
Pageof 4